Woodline Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-617,907
| Closed | -$23.7M | – | 797 |
|
|
2023
Q2 | $23.7M | Buy |
+617,907
| New | +$23.7M | 0.28% | 103 |
|
|
2023
Q1 | – | Sell |
-142,563
| Closed | -$3.74M | – | 870 |
|
|
2022
Q4 | $3.74M | Sell |
142,563
-166,821
| -54% | -$4.37M | 0.05% | 363 |
|
|
2022
Q3 | $6.08M | Sell |
309,384
-91,639
| -23% | -$1.8M | 0.09% | 263 |
|
|
2022
Q2 | $7.01M | Buy |
+401,023
| New | +$7.01M | 0.11% | 214 |
|